BioNTech SE (BNTX) Net Cash Flow (2018 - 2025)
BioNTech SE's Net Cash Flow history spans 8 years, with the latest figure at -$2.8 billion for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 2045.25% to -$2.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.7 billion, a 162.27% decrease, with the full-year FY2025 number at -$2.3 billion, down 13.77% from a year prior.
- Net Cash Flow hit -$2.8 billion in Q4 2025 for BioNTech SE, down from -$13.4 million in the prior quarter.
- Over the last five years, Net Cash Flow for BNTX hit a ceiling of $4.2 billion in Q3 2022 and a floor of -$2.9 billion in Q1 2024.
- Historically, Net Cash Flow has averaged $168.4 million across 5 years, with a median of $38.3 million in 2022.
- Biggest five-year swings in Net Cash Flow: soared 928.72% in 2022 and later tumbled 2129.52% in 2023.
- Tracing BNTX's Net Cash Flow over 5 years: stood at -$113.9 million in 2021, then soared by 928.72% to $944.2 million in 2022, then tumbled by 311.61% to -$2.0 billion in 2023, then surged by 107.28% to $145.4 million in 2024, then crashed by 2045.25% to -$2.8 billion in 2025.
- Business Quant data shows Net Cash Flow for BNTX at -$2.8 billion in Q4 2025, -$13.4 million in Q3 2025, and -$15.1 million in Q2 2025.